Zemplar and myocardial infarction 
Zemplar and myocardial infarction Patient Reports February 10, 2012
Zemplar Side Effects Report #5051415-2
Zemplar side effect was reported by a Physician from COLOMBIA on July 06, 2006. Male patient, 74 years of age, weighting 105.4 lb, was diagnosed with hyperparathyroidism secondary, hypertension, gastritis, coronary artery disease
, prophylaxis and was treated with Zemplar. After drug was administered, patient experienced the following side effects: myocardial infarction. Zemplar dosage: unknown. During the same period patient was treated with PRAZOSIN, OMEPRAZOLE, METOPROLOL TARTRATE, METOPROLOL TARTRATE, ENALAPRIL MALEATE, ENALAPRIL MALEATE, CALCIUM CARBONATE. Patient died on 06/06/2006.Zemplar Side Effects Report #5082255-6
Zemplar side effect was reported by a Physician from GERMANY on Aug 09, 2006. Male patient, 71 years of age, weighting 179.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: myocardial infarction. Zemplar dosage: unknown. During the same period patient was treated with SEVELAMER HYDROCHLORIDE, CALCIUM ACETATE, PANTOPRAZOLE, CELIPROLOL HYDROCHLORIDE, NITRENDIPINE, SIMVABETA, FUROSEMIDE, BICANORM. Patient died on 05/22/2006.
Zemplar Side Effects Report #4986877-X
Zemplar side effect was reported by a Physician from AUSTRIA on Mar 04, 2006. Male patient, 68 years of age, weighting 142.2 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: arteriosclerosis, cardiac arrest
, diabetic complication, interstitial lung disease, lipomatosis, myocardial infarction, renal disorder. Zemplar dosage: unknown. During the same period patient was treated with CALCIUM CARBONATE, CALCITRIOL. Patient died on 01/29/2006.Zemplar Side Effects Report #5794898-2
Zemplar side effect was reported by a Consumer or non-health professional from AUSTRIA on June 23, 2008. Female patient, 57 years of age, weighting 131.2 lb, was diagnosed with hyperparathyroidism secondary, diabetes mellitus, depression
, hyperlipidaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest , myocardial infarction. Zemplar dosage: unknown. During the same period patient was treated with INSULIN, METHYLPREDNISOLONE, THEOPHYLLINE, PANTOPRAZOLE, VENLAFAXINE, TRAZODONE HYDROCHLORIDE, SIMVASTATIN. Patient died on 08/07/2007.Zemplar Side Effects Report #5601798-7
Zemplar side effect was reported by a Consumer or non-health professional from GREECE on Jan 17, 2008. Male patient, 56 years of age, weighting 163.1 lb, was diagnosed with hyperparathyroidism secondary, hypertension, renal failure chronic, blood phosphorus increased and was treated with Zemplar. After drug was administered, patient experienced the following side effects: coronary artery stenosis, myocardial infarction. Zemplar dosage: unknown. During the same period patient was treated with QUINAPRIL, CLOPIDOGREL BISULPHATE, INTELECTA, FOLIC ACID, FORSENOL, CINACALCET, SEVELAMER, EVATON. Patient was hospitalized. Patient recovered.
Zemplar Side Effects Report #5747678-8
Zemplar side effect was reported by a Consumer or non-health professional from GERMANY on May 14, 2008. Male patient, 51 years of age, weighting 205.0 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: myocardial infarction, nephrogenic anaemia, pre-existing disease. Zemplar dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, CLOPIDOGREL BISULPHATE, CANDESARTAN CILEXETIL, CARVEDILOL, ALUMINIUM CHLORHYDROXIDE. Patient was hospitalized. Patient recovered.
Zemplar Side Effects Report #5261143-6
Zemplar side effect was reported by a Physician from GERMANY on Feb 28, 2007. Male patient, weighting 162.0 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute coronary syndrome, angina pectoris, cardiac disorder, coronary artery disease
, coronary artery occlusion, myocardial infarction. Zemplar dosage: unknown. Patient was hospitalized. Patient died on 01/21/2007.Zemplar Side Effects Report #5261179-5
Zemplar side effect was reported by a Physician from GERMANY on Feb 28, 2007. Male patient, weighting 148.8 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: arrhythmia
, myocardial infarction. Zemplar dosage: unknown. Patient died on 09/08/2006.Zemplar Side Effects Report #5288824-2
Zemplar side effect was reported by a Physician from GERMANY on Mar 27, 2007. Male patient, weighting 162.0 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute coronary syndrome, angina pectoris, cardiac disorder, coronary artery disease
, coronary artery occlusion, myocardial infarction. Zemplar dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, CPS PULVER, DARBEPOETIN ALFA, PRAVASTATIN STADA, IRBESARTAN, DIGITOXIN, MOLSIDOMINE, OMEPRAZOLE. Patient was hospitalized. Patient died on 01/21/2007.Zemplar Side Effects Report #5301580-4
Zemplar side effect was reported by a Physician from GERMANY on Apr 10, 2007. Male patient, weighting 162.0 lb, was diagnosed with hyperparathyroidism secondary and was treated with Zemplar. After drug was administered, patient experienced the following side effects: acute coronary syndrome, angina pectoris, cardiac disorder, coronary artery disease
, coronary artery occlusion, myocardial infarction. Zemplar dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, CPS PULVER, DARBEPOETIN ALFA, PRAVASTATIN STADA, IRBESARTAN, DIGITOXIN, MOLSIDOMINE, OMEPRAZOLE. Patient was hospitalized. Patient died on 01/21/2007.Zemplar Side Effects Report #5126251-9
Zemplar side effect was reported by a Physician from VENEZUELA on Oct 02, 2006. Female patient, weighting 88.18 lb, was diagnosed with hyperparathyroidism secondary, blood phosphorus, vitamin supplementation, hypertension, anaemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: anxiety
, myocardial infarction. Zemplar dosage: unknown. During the same period patient was treated with CALCIUM CARBONATE, FOLIC ACID, METHYLPREDNISOLONE, ATENOLOL, EPOGEN. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5700344-7
Zemplar side effect was reported by a Consumer or non-health professional from GERMANY on Mar 31, 2008. Male patient, weighting 143.3 lb, was diagnosed with hyperparathyroidism secondary, iron deficiency and was treated with Zemplar. After drug was administered, patient experienced the following side effects: atrial fibrillation
, cardiac failure, coronary artery disease , diabetic gangrene, hypertension, myocardial infarction, peripheral arterial occlusive disease, sepsis , type 2 diabetes mellitus. Zemplar dosage: unknown. During the same period patient was treated with ACETYLSALICYLIC ACID SRT, PENTAERITHRITYL TETRANITRATE, RAMIPRIL, SIMVASTATIN, THIAMAZOLE, EPOETIN BETA, FERRLECIT. Patient died on 07/23/2007.Zemplar Side Effects Report #4825671-7
Zemplar side effect was reported by a Consumer or non-health professional from VENEZUELA on Nov 01, 2005. Female patient, weighting 122.4 lb, was diagnosed with hyperparathyroidism secondary, mineral supplementation, vitamin supplementation, myalgia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: myocardial infarction. Zemplar dosage: unknown. During the same period patient was treated with CALCIUM CARBONATE, FOLIC ACID, ORPHENADRINE, IBUPROFEN, OMEPRAZOLE, VITMAIN, HEPARIN. Patient died on 10/29/2005.
Zemplar Side Effects Report #5118921-3
Zemplar side effect was reported by a Physician from AUSTRIA on Sept 24, 2006. Male patient, 65 years of age, weighting 160.9 lb, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: myocardial infarction. Zemplar dosage: unknown. During the same period patient was treated with FOSRENOL, DARBEPOETIN ALFA, FOLIC ACID, NULYTELY, PRAVASTATIN, ASPIRIN, TRIAZOLAM, GLYCERYL TRINITRATE. Patient was hospitalized. Patient died on 08/29/2006.
Zemplar Side Effects Report #5944062-9
Zemplar side effect was reported by a Consumer or non-health professional from CROATIA (local name: Hrvatska) on Nov 03, 2008. Male patient, 59 years of age, weighting 154.3 lb, was diagnosed with hyperparathyroidism, hyperphosphataemia, hypertension, anaemia, angina pectoris and was treated with Zemplar. After drug was administered, patient experienced the following side effects: myocardial infarction. Zemplar dosage: unknown. During the same period patient was treated with SEVELAMER, VALSARTAN, LACIDIPINE, EPOETIN ALFA, ISOSORBID MN RETARD. Patient died on 09/09/2008.
Zemplar Side Effects Report #5947213-5
Zemplar side effect was reported by a Consumer or non-health professional from CROATIA (local name: Hrvatska) on Nov 10, 2008. Male patient, 59 years of age, weighting 154.3 lb, was diagnosed with hyperparathyroidism, hyperphosphataemia, hypertension, anaemia, angina pectoris and was treated with Zemplar. After drug was administered, patient experienced the following side effects: myocardial infarction. Zemplar dosage: unknown. During the same period patient was treated with SEVELAMER, VALSARTAN, LACIDIPINE, EPOETIN ALFA, ISOSORBID MN RETARD. Patient died on 09/09/2008.
Zemplar Side Effects Report #5953681-5
Zemplar side effect was reported by a Consumer or non-health professional from CROATIA (local name: Hrvatska) on Nov 10, 2008. Male patient, 59 years of age, weighting 154.3 lb, was diagnosed with hyperparathyroidism, hyperphosphataemia, hypertension, anaemia, angina pectoris and was treated with Zemplar. After drug was administered, patient experienced the following side effects: myocardial infarction. Zemplar dosage: unknown. During the same period patient was treated with SEVELAMER, VALSARTAN, LACIDIPINE, EPOETIN ALFA, ISOSORBID MN RETARD. Patient died on 09/09/2008.
Zemplar Side Effects Report #5680824-3
Zemplar side effect was reported by a Consumer or non-health professional from AUSTRIA on Mar 19, 2008. Female patient, 57 years of age, weighting 131.2 lb, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest
, myocardial infarction. Zemplar dosage: unknown. Patient died on 08/07/2007.Zemplar Side Effects Report #6097855-4
Zemplar side effect was reported by a Consumer or non-health professional from CROATIA (local name: Hrvatska) on Feb 19, 2009. Male patient, 52 years of age, weighting 123.5 lb, was diagnosed with hyperparathyroidism, hypertension, gastritis, hyperlipidaemia, hyperphosphataemia and was treated with Zemplar. After drug was administered, patient experienced the following side effects: chest pain
, embolism, myocardial infarction. Zemplar dosage: unknown. During the same period patient was treated with NIFEDIPINE, RANITIDINE, ATORVASTATIN, SEVELAMER HYDROCHLORIDE, SEVELAMER HYDROCHLORIDE. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #6075901-1
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 09, 2009. Male patient, weighting 256.2 lb, was diagnosed with hyperparathyroidism, vitamin supplementation, hypotension, reflux oesophagitis, hypertension, blood cholesterol increased, renal disorder, diabetes mellitus and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest
, diabetes mellitus, hyperlipidaemia, malaise, myocardial infarction, renal failure. Zemplar dosage: unknown. During the same period patient was treated with SENSIPAR, FERROUS SULPHATE, MIDODRINE, ACIPHEX, GEMFIBROZIL, VYTORIN, RENAGEL, AVANDIA. Patient died on 10/26/2008.Zemplar Side Effects Report #6078725-4
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 13, 2009. Male patient, weighting 256.2 lb, was diagnosed with hyperparathyroidism, mineral supplementation, hypotension, gastrooesophageal reflux disease, hypertension, blood cholesterol increased, renal disorder, diabetes mellitus and was treated with Zemplar. After drug was administered, patient experienced the following side effects: cardiac arrest
, diabetes mellitus, hyperlipidaemia, malaise, myocardial infarction, renal failure. Zemplar dosage: unknown. During the same period patient was treated with SENSIPAR, FERROUS SULPHATE, MIDODRINE, ACIPHEX, GEMFIBROZIL, VYTORIN, RENAGEL, AVANDIA. Patient died on 10/26/2008.Zemplar Side Effects Report #6079291-X
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 10, 2009. Female patient, weighting 102.1 lb, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: coronary artery bypass
, coronary artery occlusion, infection , myocardial infarction, pyrexia. Zemplar dosage: unknown. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #6080322-1
Zemplar side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 10, 2009. Female patient, weighting 102.1 lb, was diagnosed with hyperparathyroidism and was treated with Zemplar. After drug was administered, patient experienced the following side effects: coronary artery occlusion, infection
, myocardial infarction, pyrexia. Zemplar dosage: unknown. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5699552-3
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on Apr 03, 2008. Male patient, 49 years of age, was diagnosed with diabetic nephropathy and was treated with Zemplar. After drug was administered, patient experienced the following side effects: myocardial infarction. Zemplar dosage: 5 MCG/ML. During the same period patient was treated with CLOPIDOGREL, ACETYLSALICYLIC ACID SRT, BETA BLOCKING AGENTS, GLYCERYL TRINITRATE. Patient was hospitalized. Patient recovered.
Zemplar Side Effects Report #5569598-4
Zemplar side effect was reported by a Consumer or non-health professional from GERMANY on Dec 10, 2007. Male patient, weighting 174.2 lb, was diagnosed with blood parathyroid hormone increased and was treated with Zemplar. After drug was administered, patient experienced the following side effects: myocardial infarction. Zemplar dosage: unknown. Patient died on 04/16/2007.
Zemplar Side Effects Report #5761354-7
Zemplar side effect was reported by a Consumer or non-health professional from SWEDEN on May 29, 2008. Female patient, 62 years of age, was diagnosed with acidosis, gastrooesophageal reflux disease, constipation
and was treated with Zemplar. After drug was administered, patient experienced the following side effects: atelectasis, chest discomfort, dyspnoea, ejection fraction abnormal, hypocalcaemia, myocardial infarction, pleural effusion, upper respiratory tract infection. Zemplar dosage: 5 MCG/ML. During the same period patient was treated with BICARBONATE, OMEPRAZOLE, LACTULOSE, HUMALOG PEN, LANTUS OPTISET, ALFACALCIDOL, TRIOBE, ORALVITE. Patient was hospitalized. Patient recovered.Zemplar Side Effects Report #5288818-7
Zemplar side effect was reported by a Physician from GERMANY on Mar 29, 2007. Male patient, 39 years of age, was treated with Zemplar. After drug was administered, patient experienced the following side effects: myocardial infarction. Zemplar dosage: unknown. Patient recovered.